Director
CurrentReveraGen is a drug development company engaged in the discovery and development of proprietary therapeutic products for neuromuscular and inflammatory diseases. They are pursuing small molecule drug development for selected indications. ReveraGen’s lead compound, VBP15, is a novel anti-inflammatory currently in development for the chronic treatment of.